Pharco Pharma will begin work on its EGP 1 bn oncologicals plant this week, Al Borsa reports. The new venture, the Egyptian National Company for Medical Products (We Can), will build Egypt’s first oncology medicine factory at a total cost of EGP 500 mn, of which 50% will be covered by banks. The project is part of a cooperation agreement that Pharco had signed with the Health and Military Production Ministries and domestic vaccine producer Vacsera back in August. The factory will be built at Vacsera’s industrial complex in 6 October over 61k sqm and is expected to manufacture 93 different types of meds once it’s operational in two years’ time, according to Pharco’s CEO Shereen Helmy. We reported last week that the Egyptian Arab Land Bank was arranging financing for the facility.
More from Enterprise
Four foreign funds line up USD 256 mn for Banque du Caire
London’s Redwheel is among the backers, nearly two weeks after…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
FRA and EGX eye law change to let LLCs and partnerships set up investment funds
Regulators want to keep Egyptian money from setting up funds…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…